| dc.contributor.author | Biricik, H. S. | |
| dc.contributor.author | Cabalar, M. | |
| dc.contributor.author | Gulbahar, M. Y. | |
| dc.date.accessioned | 2020-06-21T15:13:04Z | |
| dc.date.available | 2020-06-21T15:13:04Z | |
| dc.date.issued | 2008 | |
| dc.identifier.issn | 0001-7213 | |
| dc.identifier.issn | 1801-7576 | |
| dc.identifier.uri | https://doi.org/10.2754/avb200877030373 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/19171 | |
| dc.description | GULBAHAR, MUSTAFA YAVUZ/0000-0001-8268-7659 | en_US |
| dc.description | WOS: 000259640100010 | en_US |
| dc.description.abstract | The efficacy of taurolidine on the treatment of oral papillomatosis in a 1-year-old Turkish Kangal dog was evaluated. Diagnosis of the papillomatosis was based on clinical signs, histopathological and immunohistochemical examinations. The dog received 45 mg/kg taurolidine intravenously every 3 days. Regression of papillomas started to be observed after the beginning of treatment, and complete resolution occurred after the fifth application. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Veterinarni A Farmaceuticka Univerzita Brno | en_US |
| dc.relation.isversionof | 10.2754/avb200877030373 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | papillomatosis | en_US |
| dc.subject | taurolidine | en_US |
| dc.subject | dog | en_US |
| dc.title | Oral papillomatosis in a dog and its therapy with taurolidine | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 77 | en_US |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.startpage | 373 | en_US |
| dc.identifier.endpage | 375 | en_US |
| dc.relation.journal | Acta Veterinaria Brno | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
